Compare QRHC & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QRHC | GNTA |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | Italy |
| Employees | N/A | 13 |
| Industry | Environmental Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 19.9M |
| IPO Year | 2008 | N/A |
| Metric | QRHC | GNTA |
|---|---|---|
| Price | $1.14 | $0.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.2K | ★ 38.1K |
| Earning Date | 05-07-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $138,346,327.00 | N/A |
| Revenue This Year | $3.67 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.81 | $0.59 |
| 52 Week High | $2.64 | $10.00 |
| Indicator | QRHC | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 44.37 | 49.00 |
| Support Level | $1.08 | $0.71 |
| Resistance Level | $1.36 | $0.75 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 25.00 | 65.56 |
Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations, etc.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.